Skip to main content
Top
Published in: BMC Nephrology 1/2021

Open Access 01-12-2021 | Echocardiography | Research article

Association of maximal stress ergometry performance with troponin T and abdominal aortic calcification score in advanced chronic kidney disease

Authors: Roosa Lankinen, Markus Hakamäki, Kaj Metsärinne, Niina Koivuviita, Jussi P. Pärkkä, Maria Saarenhovi, Tapio Hellman, Mikko J. Järvisalo

Published in: BMC Nephrology | Issue 1/2021

Login to get access

Abstract

Background

Cardiac biomarkers Troponin T (TnT) and N-terminal pro-B-type natriuretic peptide (proBNP) and abdominal aortic calcification score (AAC) are associated with cardiovascular events and mortality in patients with chronic kidney disease (CKD). The effects of cardiac biomarkers and AAC on maximal exercise capacity in CKD are unknown and were studied.

Methods

One hundred seventy-four CKD 4–5 patients not on maintenance dialysis underwent maximal bicycle ergometry stress testing, lateral lumbar radiograph to study AAC, echocardiography and biochemical assessments.

Results

The subjects with proportional maximal ergometry workload (WMAX%) less than 50% of the expected values had higher TnT, proBNP, AAC, left ventricular end-diastolic diameter, left ventricular mass index, E/e’ and pulse pressure, and lower global longitudinal strain compared to the better performing patients. TnT (β = − 0.09, p = 0.02), AAC (β = − 1.67, p < 0.0001) and diabetes (β = − 11.7, p < 0.0001) remained significantly associated with WMAX% in the multivariable model. Maximal ergometry workload (in Watts) was similarly associated with TnT and AAC in addition to age, male gender, hemoglobin and diastolic blood pressure in a respective multivariate model.
AAC and TnT showed fair predictive power for WMAX% less than 50% of the expected value with AUCs of 0.70 and 0.75, respectively.

Conclusions

TnT and AAC are independently associated with maximal ergometry stress test workload in patients with advanced CKD.

Trial registration

Appendix
Available only for authorised users
Literature
1.
go back to reference Padilla J, Krasnoff J, Da Silva M, et al. Physical functioning in patients with chronic kidney disease. J Nephrol. 2008;21(4):550–9.PubMed Padilla J, Krasnoff J, Da Silva M, et al. Physical functioning in patients with chronic kidney disease. J Nephrol. 2008;21(4):550–9.PubMed
3.
go back to reference Sietsema KE, Amato A, Adler SG, et al. Exercise capacity as a predictor of survival among ambulatory patients with end-stage renal disease. Kidney Int. 2004;65(2):719–24.CrossRef Sietsema KE, Amato A, Adler SG, et al. Exercise capacity as a predictor of survival among ambulatory patients with end-stage renal disease. Kidney Int. 2004;65(2):719–24.CrossRef
5.
go back to reference Newby LK, Jesse RL, Babb JD, Christenson RH, De Fer TM, Diamond GA, et al. ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on clinical expert consensus documents. J Am Coll Cardiol. 2012;60(23):2427–63. https://doi.org/10.1016/j.jacc.2012.08.969.CrossRefPubMed Newby LK, Jesse RL, Babb JD, Christenson RH, De Fer TM, Diamond GA, et al. ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on clinical expert consensus documents. J Am Coll Cardiol. 2012;60(23):2427–63. https://​doi.​org/​10.​1016/​j.​jacc.​2012.​08.​969.CrossRefPubMed
8.
10.
go back to reference KDIGO Work Group. Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(Suppl 3):1–150. KDIGO Work Group. Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(Suppl 3):1–150.
14.
19.
go back to reference Hosmer DW, Lemeshow S. Applied logistic regression, 2nd Ed. Chapter 5. New York: Wiley; 2000. p. 160–4.CrossRef Hosmer DW, Lemeshow S. Applied logistic regression, 2nd Ed. Chapter 5. New York: Wiley; 2000. p. 160–4.CrossRef
20.
go back to reference K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in Dialysis patients. Am J Kidney Dis. 2005;45(4 Suppl 3):S1–153. K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in Dialysis patients. Am J Kidney Dis. 2005;45(4 Suppl 3):S1–153.
21.
24.
Metadata
Title
Association of maximal stress ergometry performance with troponin T and abdominal aortic calcification score in advanced chronic kidney disease
Authors
Roosa Lankinen
Markus Hakamäki
Kaj Metsärinne
Niina Koivuviita
Jussi P. Pärkkä
Maria Saarenhovi
Tapio Hellman
Mikko J. Järvisalo
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2021
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-021-02251-y

Other articles of this Issue 1/2021

BMC Nephrology 1/2021 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.